Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neuronetics Inc.

5.01
+0.07001.42%
Post-market: 5.010.00000.00%16:05 EDT
Volume:1.06M
Turnover:5.35M
Market Cap:319.03M
PE:-3.67
High:5.16
Open:5.11
Low:4.91
Close:4.94
Loading ...

Company Profile

Company Name:
Neuronetics Inc.
Exchange:
NASDAQ
Establishment Date:
2001
Employees:
201
Office Location:
3222 Phoenixville Pike,Malvern,Pennsylvania,United States
Zip Code:
19355
Fax:
610 640 4206
Introduction:
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Directors

Name
Position
Brian Farley
Chairman of the Board
Chris Thatcher
President and Chief Executive Officer and Director
Glenn Muir
Director
Paulina Hill
Director
Ron Hunt
Director
Stephen Campe
Director
Wilfred Jaeger
Director

Shareholders

Name
Position
Chris Thatcher
President and Chief Executive Officer and Director
Peter Donato
Vice President and Chief Financial Officer
Daniel Guthrie
Chief Commercial Officer
Gregory Harper
Vice President of Research and Development, Operations and Product Development
Yelena Tropsha
Vice President, Commercial Access